Adenovirus vaccine vector and methods of use
US-9198959-B2 · Dec 1, 2015 · US
US9555103B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9555103-B2 |
| Application number | US-201214362545-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 6, 2012 |
| Priority date | Dec 7, 2011 |
| Publication date | Jan 31, 2017 |
| Grant date | Jan 31, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a nutritional, preferably enteral, composition for use in the treatment of cow's milk allergy in infants allergic to cow's milk containing specific beta-lactoglobulin peptides, which are able to reduce, in particular abolish the acute symptoms of cow's milk protein allergy.
Opening claim text (preview).
The invention claimed is: 1. A nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants, the nutritional composition comprising at least one beta-lactoglobulin peptide comprising an amino acid sequence consisting of 18 to 30 amino acids and having an amino acid sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, and SEQ ID NO 3, wherein the composition comprises 10 to 5000 μg of the at least one beta-lactoglobin peptide per g of total protein in the composition. 2. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , comprising as a further protein component free amino acids and/or extensively hydrolyzed proteins. 3. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , comprising at least one non-digestible oligosaccharide selected form the group consisting of fructo-oligosaccharide, non-digestible dextrin, galacto-oligosaccharide, xylo-oligosaccharide, arabino-oligosaccharide, arabinogalacto-oligosaccharide, gluco-oligosaccharide, glucomanno-oligosaccharide, galactomanno-oligosaccharide, mannan-oligosaccharide, chito-oligosaccharide, uronic acid oligosaccharide, sialyl-oligosaccharide and fuco-oligosaccharide. 4. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 3 , wherein the non-digestible oligosaccharide is a short-chain or long-chain fructo-oligosaccharide. 5. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , comprising a lipid component and at least one digestible carbohydrate. 6. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , wherein the composition comprises a total amount of protein of 5 to 25° A) based on dry weight of the composition. 7. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 3 , wherein the composition comprises 0.05 to 20 wt. % of the at least one non-digestible oligosaccharide based on dry weight of the composition. 8. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 5 , wherein the composition comprises 15 to 40% of the lipid component based on dry weight of the composition. 9. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , which is an infant formula or a follow-on-formula. 10. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , which is in the form of a dry powder or a ready to feed liquid. 11. A nutritional composition comprising at least one beta-lactoglobulin peptide comprising an amino acid sequence consisting of 18 to 30 amino acids and having an amino acid sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, and SEQ ID NO 3, wherein the composition comprises 10 to 5000 μg of the at least one beta-lactoglobin peptide per g of total protein in the composition, and wherein the at least one beta-lactoglobulin peptide is for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants. 12. A nutritional composition comprising a protein component, a lipid component and digestible carbohydrates, wherein the protein component consists of i) the at least one beta-lactoglobulin peptide according to claim 1 , and ii) at least one further protein component selected from the group consisting of extensively hydrolysed protein and free amino acids, wherein in sum of i) and ii) accounts for at least 95 wt. % of the protein component, and wherein the lipid component comprises at least 0.1 wt. % DHA based on total fatty acids. 13. The nutritional composition according to claim 12 , comprising at least one non-digestible oligosaccharide, wherein the non-digestible oligosaccharide is a short-chain or long-chain fructo-oligosaccharide. 14. The nutritional composition according to claim 12 , wherein the composition comprises a total amount of protein of 5 to 25° A) based on dry weight of the composition. 15. The nutritional composition according to claim 12 , which is an infant formula or a follow-on-formula. 16. The nutritional composition according to claim 12 , which is an infant formula or a follow-on-formula for use in feeding cow's milk protein allergic infants. 17. The nutritional composition for use in the treatment of cow's milk protein allergy in cow's milk protein allergic infants according to claim 1 , wherein the at least one beta-lactoglobulin peptide is SEQ DI NO 3. 18. A nutritional composition comprising at least one beta-lactoglobulin peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO 1, SEQ ID NO 2, and SEQ ID NO 3. 19. The nutritional composition according to claim 18 , further comprising a protein component selected from the group consisting of hydrolysed whey protein, free amino acids, soy proteins, hydrolysed soy proteins, pea proteins, hydrolysed pea proteins, rice proteins, hydrolysed rice proteins, collagen, hydrolysed collagen, and mixtures thereof. 20. The nutritional composition according to claim 18 , further comprising a lipid component and a carbohydrate component.
Peptides; Protein hydrolysates · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Dairy proteins · CPC title
Allergens · CPC title
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.